MAGELLAN LONGEVITY
HomeResearchStudy library › Leukocyte telomere length, cancer incidence and all-cause mortality…
Study summary · Biological age, epigenetics & aging clocks

What is the association between leukocyte telomere length and the risk of cancer incidence and all-cause mortality in a large prospective cohort of Chinese adults?

In one paragraph

Telomere Support (Int J Cancer 2020, PMID 33459354) — longer telomeres were associated with a lower risk of all-cause mortality (HR = 0.93), noncancer death (HR = 0.81), and specifically, death from chronic obstructive pulmonary disease and pneumonia (HR = 0.79) and digestive diseases (HR = 0.60). The abstract for Telomere Support states no limitations.

Source: Int J Cancer 2020, PMID 33459354 ↗ · Research map · How Magellan grades evidence · evidence confidence: medium

Int J Cancer · 2020 · PMID 33459354 · DOI 10.1002/ijc.33211

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Longer telomeres are linked to a higher risk of cancer but a lower risk of non-cancer related death in Chinese adults.

The question

What is the association between leukocyte telomere length and the risk of cancer incidence and all-cause mortality in a large prospective cohort of Chinese adults?

What they tested

The study aims to investigate the association of leukocyte telomere length with risk of cancer incidence and all-cause mortality.

How they did it

Relative telomere lengths were quantified using quantitative real-time PCR in genomic DNA from peripheral blood samples of 26,540 middle-aged or older Chinese adults. Hazard ratios (HRs) and 95% confidence intervals (CIs) for cancer and deaths by quintiles of telomere length were calculated using Cox proportional hazards regression, adjusted for age, sex, and other potential confounders.

What they found

After baseline, 4,353 persons developed cancer and 7,609 died. Participants with the longest decile of telomeres had a 26% higher risk of total cancer incidence compared to the shortest decile. Longer telomeres were associated with a lower risk of all-cause mortality (HR = 0.93), noncancer death (HR = 0.81), and specifically, death from chronic obstructive pulmonary disease and pneumonia (HR = 0.79) and digestive diseases (HR = 0.60).

Association of Telomere Length with Cancer Incidence and Mortality
Values shown: Risk/Hazard Ratio
Total Cancer Incidence (Longest vs. Shortest Decile)26
All-Cause Mortality (Longer Telomeres)0.93
Noncancer Death (Longer Telomeres)0.81
Death from COPD and Pneumonia (Longer Telomeres)0.79
Death from Digestive Diseases (Longer Telomeres)0.6

The chart shows the percentage increase in total cancer incidence for the longest telomere decile compared to the shortest, and hazard ratios for different mortality outcomes associated with longer telomeres.

What it means

Longer telomeres are associated with an increased risk of overall cancer development and several specific cancer types, but also with a reduced risk of noncancer-related death.

Limitations

The abstract does not explicitly state any limitations of the study.

Where the published abstract does not list limitations, we say so rather than inventing them. Read the full paper on PubMed before drawing conclusions.

“longer telomeres are associated with reduced risk of all-cause mortality”— from the published abstract, Int J Cancer 2020

The paper at a glance

TitleLeukocyte telomere length, cancer incidence and all-cause mortality among Chinese adults
JournalInt J Cancer
Year2020
PMID33459354 ↗
DOI10.1002/ijc.33211 ↗
TopicBiological age, epigenetics & aging clocks

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Telomere Support

Telomere attrition is one of the recognised hallmarks of aging, and shorter telomeres are associated in meta-analyses with increased all-cause mortality and age-related disease. Protecting telomere length is therefore a target of interest, though it is one factor among many in biological aging.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). What is the association between leukocyte telomere length and the risk of cancer incidence and all-cause mortality in a large prospective cohort of Chinese adults? [Plain-English summary of Int J Cancer 2020, PMID 33459354, DOI 10.1002/ijc.33211]. Magellan Longevity. https://magellanlongevity.com/study/x9.html
BibTeX
@misc{magellan_x9, title = {What is the association between leukocyte telomere length and the risk of cancer incidence and all-cause mortality in a large prospective cohort of Chinese adults?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/x9.html}}, note = {Plain-English summary of PubMed PMID 33459354; DOI 10.1002/ijc.33211; Int J Cancer 2020. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/x9.html

Related studies in the Magellan library

All 5 Magellan summaries on biological age, epigenetics & aging clocks →

How this summary was made. Every section above restates what the published abstract of PMID 33459354 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.